Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base
10:10am, Thursday, 24'th Oct 2024
Quest Diagnostics benefits from an aging population, driving increased lab testing volumes, particularly in genetic testing, and offers a 2.0% dividend yield. DGX's M&A strategy, including the LifeLab
Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
08:36am, Thursday, 24'th Oct 2024
Quest Diagnostics reported strong Q3 earnings, with an 8.5% revenue increase and a 3.6% rise in diluted EPS, beating Street expectations. The company raised its 2024 revenue guidance and expects signi
DGX or PNTG: Which Is the Better Value Stock Right Now?
12:45pm, Wednesday, 23'rd Oct 2024
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Quest Diagnostics (DGX) or The Pennant Group, Inc. (PNTG). But which of these two comp
4 Stocks to Buy in an Evolving Outpatient Home Health Industry
12:05pm, Wednesday, 23'rd Oct 2024
Dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, AMED and ADUS are well-poised
US lab operator Quest Diagnostics to launch bird flu test at end of October
08:08am, Wednesday, 23'rd Oct 2024
Lab operator Quest Diagnostics said on Wednesday it will launch a test for H5N1 bird flu at the end of October after the U.S. Centers for Disease Control and Prevention (CDC) gave it contracts to supp
Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development
07:53am, Wednesday, 23'rd Oct 2024
Quest to develop laboratory tests and support public health reporting and laboratory readiness for CDC's preparedness strategy; Company to introduce clinical testing for avian flu later this month ba
Overlooked Stock: DGX
04:57pm, Tuesday, 22'nd Oct 2024
One of the biggest earnings movers from Tuesday: Quest Diagnostics (DGX). The lab & testing company beat on the top-and-bottom line in its 3Q report, as shares surged to multi-month highs.
Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript
11:40am, Tuesday, 22'nd Oct 2024
Quest Diagnostics Incorporated (NYSE:DGX ) Q3 2024 Earnings Conference Call October 22, 2023 8:30 AM ET Company Participants Jim Davis - President, Chief Executive Officer Sam Samad - Executive Vice P
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025
11:08am, Tuesday, 22'nd Oct 2024
Quest Diagnostics Inc DGX posted third-quarter adjusted earnings per share of $2.30, beating the consensus of $2.26.
DGX Stock Rises on Q3 Earnings and Revenue Beat, 2024 Sales View Up
10:40am, Tuesday, 22'nd Oct 2024
Quest Diagnostics' third-quarter 2024 performance reflects impressive DIS business growth and the benefits of new acquisitions.
Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates
09:00am, Tuesday, 22'nd Oct 2024
Quest Diagnostics (DGX) came out with quarterly earnings of $2.30 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.22 per share a year ago.
Quest Diagnostics beats quarterly results estimates on diagnostic test demand
08:05am, Tuesday, 22'nd Oct 2024
Laboratory operator Quest Diagnostics beat Wall Street estimates for third-quarter profit and revenue on Tuesday, helped by robust demand for its diagnostic tests.
Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024
06:45am, Tuesday, 22'nd Oct 2024
Third quarter revenues of $2.49 billion, up 8.5% from 2023 Third quarter reported diluted earnings per share ("EPS") of $1.99, up 1.5% from 2023; and adjusted diluted EPS of $2.30, up 3.6% from 2023 F
Are Investors Undervaluing Quest Diagnostics (DGX) Right Now?
10:45am, Wednesday, 16'th Oct 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Quest Diagnostics (DGX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Tuesday, 15'th Oct 2024
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
